Amyloid fibril-specific chimeric antigen receptor macrophages (car-m)-based immunotherapy for amyloid clearance in light chain amyloidosis

Ended Project Grant Awarded Last action

Award ID
W81XWH2110607
Recipient
Awarding agency
Obligated
$161,999

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
New York, NY 10032, USA

Award details come from USAspending.gov.

About this award

The Department of the Army Medical Command awarded a $162,000 project grant to The Trustees of Columbia University in New York, NY under the Military Medical Research and Development program. The grant supports the development of amyloid fibril-specific chimeric antigen receptor macrophages (CAR-M)-based immunotherapy for amyloid clearance in light chain amyloidosis from August 1, 2021 through July 31, 2023. The Military Medical Research and Development program (CFDA 12.420) aims to conduct basic, applied, and advanced biomedical research to improve military and public health care through innovative medical solutions. This award will fund research into a novel CAR-M immunotherapy approach targeting the removal of amyloid deposits from tissues in patients with light chain amyloidosis, a rare disease caused by abnormal proteins building up in organs.

Transactions

Action Obligated Date
Amendment 161,999THE purpose of this modification is to: 1) provide a one year no cost extension (NCE) to the period of performance, extending the end date to 31 july… $0
Original award $161,999

Quick answers

Who received award W81XWH2110607?

W81XWH2110607 was awarded to The Trustees Of Columbia University In The City Of New York by Medical Command (Department of the Army) on August 1, 2021.

How much is award W81XWH2110607 worth?

$161,999 has been obligated on W81XWH2110607.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award